CN113318262A - 一种具有杀菌作用的卫生护理垫 - Google Patents
一种具有杀菌作用的卫生护理垫 Download PDFInfo
- Publication number
- CN113318262A CN113318262A CN202110748041.9A CN202110748041A CN113318262A CN 113318262 A CN113318262 A CN 113318262A CN 202110748041 A CN202110748041 A CN 202110748041A CN 113318262 A CN113318262 A CN 113318262A
- Authority
- CN
- China
- Prior art keywords
- layer
- surface layer
- parts
- nursing pad
- sanitary nursing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000474 nursing effect Effects 0.000 title claims abstract description 48
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 6
- 239000000463 material Substances 0.000 claims abstract description 67
- 239000010410 layer Substances 0.000 claims abstract description 49
- 238000010521 absorption reaction Methods 0.000 claims abstract description 39
- 239000007788 liquid Substances 0.000 claims abstract description 30
- 239000002344 surface layer Substances 0.000 claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 27
- 239000011347 resin Substances 0.000 claims abstract description 21
- 229920005989 resin Polymers 0.000 claims abstract description 21
- 230000001954 sterilising effect Effects 0.000 claims abstract description 21
- 239000002250 absorbent Substances 0.000 claims abstract description 19
- 230000002745 absorbent Effects 0.000 claims abstract description 18
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 16
- 238000002791 soaking Methods 0.000 claims abstract description 14
- 229920000742 Cotton Polymers 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 10
- 241000723346 Cinnamomum camphora Species 0.000 claims description 10
- 229930008380 camphor Natural products 0.000 claims description 10
- 229960000846 camphor Drugs 0.000 claims description 10
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 9
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 9
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 241000213006 Angelica dahurica Species 0.000 claims description 5
- 241000972672 Phellodendron Species 0.000 claims description 5
- 241000219061 Rheum Species 0.000 claims description 5
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 229920000058 polyacrylate Polymers 0.000 claims description 4
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 claims description 4
- 238000003825 pressing Methods 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 235000012239 silicon dioxide Nutrition 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 240000004980 Rheum officinale Species 0.000 claims description 3
- 235000008081 Rheum officinale Nutrition 0.000 claims description 3
- 238000004026 adhesive bonding Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 35
- 230000001737 promoting effect Effects 0.000 abstract description 19
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- 230000017531 blood circulation Effects 0.000 abstract description 14
- 206010061218 Inflammation Diseases 0.000 abstract description 11
- 230000004054 inflammatory process Effects 0.000 abstract description 11
- 230000003467 diminishing effect Effects 0.000 abstract description 9
- 238000000554 physical therapy Methods 0.000 abstract description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 10
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 10
- 208000004210 Pressure Ulcer Diseases 0.000 description 10
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 10
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 10
- 229940116229 borneol Drugs 0.000 description 10
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 10
- 231100000331 toxic Toxicity 0.000 description 10
- 230000002588 toxic effect Effects 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 241000245665 Taraxacum Species 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 241001570521 Lonicera periclymenum Species 0.000 description 8
- 206010042674 Swelling Diseases 0.000 description 8
- 241000411851 herbal medicine Species 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 229920000247 superabsorbent polymer Polymers 0.000 description 7
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 241000555712 Forsythia Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000972673 Phellodendron amurense Species 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 240000000572 Blumea balsamifera Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 244000167230 Lonicera japonica Species 0.000 description 2
- 235000017617 Lonicera japonica Nutrition 0.000 description 2
- 240000000233 Melia azedarach Species 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 244000299492 Thespesia populnea Species 0.000 description 2
- 235000009430 Thespesia populnea Nutrition 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000007863 gel particle Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 241000984231 Atractylodes chinensis Species 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000034347 Faecal incontinence Diseases 0.000 description 1
- 241000576429 Forsythia suspensa Species 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 240000009134 Physalis philadelphica Species 0.000 description 1
- 235000002489 Physalis philadelphica Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001309 inhibitory effect on influenza Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- -1 luteolin glycoside Chemical class 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000010094 polymer processing Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Invalid Beds And Related Equipment (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种具有杀菌作用的卫生护理垫，其技术方案要点是：由表面层、吸收层和底层构成，所述表面层由纯棉和PE网状材质组合构成，所述吸收层的主要成分为高吸水树脂，所述底层由透气材料制成，所述表面层和吸收层在组合后还经过中药药液浸泡处理。本发明提供一种功能卫生护理垫，通过浸泡中药药液处理，从而使护理垫具有一定中药理疗效果，使产品起到起到杀菌作用，具有消炎、活血化瘀等作用。
Description
本申请是分案申请，原申请的申请号为201810522407.9，申请日为：2018年05月28日，发明名称为：一种功能卫生护理垫及其制备方法。
【技术领域】
本发明属于医疗卫生护理用品技术领域，具体涉及一种具有杀菌作用的卫生护理垫。
【背景技术】
在医院、养老院和居民家庭中，病人需要用到卫生护理垫，特别是卧床病人或丧失生活自理能力的病人，卫生护理垫是必不可少的日常用品。目前国内卫生护理垫生产企业众多，产品类型多种多样，随着中国人口老龄化程度日益严重，老年人护理机构不断增加，对卫生护理垫的需求会越来越大，病人长期卧床，长褥疮的可能性随时存在，因此，市场需要具有防止褥疮生长、灭菌消炎、活血化瘀等独特功能的卫生护理垫。作为一次性消费品，不但要考虑使用成本，同时也必须研究材料的环保性能，使用后的废弃物能够生物降解，不对环境造成污染。
卫生护理垫主要材料为高吸水性聚合物SAP(Super Absorbent Polymer)，或高吸水树脂SAR(Super Absorbent Resin)这类树脂种类多达数十种，高吸水树脂新材料的研发和应用是材料学科研究的热点。
将中草药中有效成分提取处理，按照功能区分，分为灭菌消炎、活血化瘀等不同类型，制成易于附着于SAP材料的剂型，处理后的附有中草药有效成分SAP材料进一步加工成为所需规格的卫生护理垫。
卫生护理垫规格有以下六种：8cm×8cm；30cm×30cm；25cm×40cm；45cm×60cm；60cm×60cm；60cm×90cm。或根据特殊规格要求加工成型。卫生护理垫所用材料必须符合医用卫生材料标准要求，全部加工材料经过检验合格，与人体接触的材料已在临床上应用过，其安全性、可靠性符合卫生标准要求，加工后的卫生护理垫外观应展开为片状，厚薄均匀，无污点，无异味，符合一次性使用病床、检查床、家庭护理床上用的卫生护理用品，可用于用于卧床病人保洁或预防褥疮，加工成型的医用护理垫应符合卫生标准，细菌菌落总数≤200cfu/g，真菌菌落总数≤100cfu/g，大肠菌群不得检出，致病性化脓菌不得检出。
【发明内容】
本发明的目的是克服现有技术的不足，提供一种具有杀菌作用的卫生护理垫，通过浸泡中药药液处理，从而使护理垫具有一定中药理疗效果，使产品起到防止褥疮生长、消炎、活血化瘀等作用。
本发明还提供一种具有杀菌作用的卫生护理垫的制备方法。
本发明技术方案如下：
一种具有杀菌作用的卫生护理垫，由表面层、吸收层和底层构成，所述表面层由纯棉和PE网状材质组合构成，所述吸收层的主要成分为高吸水树脂，所述底层由透气材料制成，所述表面层和吸收层在组合后还经过中药药液浸泡处理。
优选的，所述中药药液主要由大黄、白芷、黄柏、樟脑、薄荷制成。
优选的，所述中药药液主要由连翘、蒲公英、金银花、冰片、苍术制成。
优选的，所述吸收层由45～55份糊化淀粉液、15～30份丙烯酸、10～12份丙烯酰胺、6～9份过硫酸钾、20～30份去离子水、10～15份纤维素接枝的聚丙烯酸酯、3～5份甘油、2～5份二氧化硅，在110～125℃条件搅拌混合并超声分散制得。本申请所使用的高吸水树脂稳定性高，通过其内部的微小结构有效改善调湿材料对外界环境下调湿速率，有效提高调湿材料对环境的响应速率，而设计使用无机矿物类进行结构调节，多孔结构内能够吸附和释放水蒸气，通过制备的凝胶颗粒为负载载体，由于凝胶材料表面无皱缩、裂纹和塌陷，内部呈三维多孔网状结构，具有较高的比表面积，将本发明通过聚合制备的纳米吸水树脂微球填充至材料内部，从而有效延缓吸水效应，使其吸水饱和，而当吸水树脂颗粒失水皱缩后，干凝胶颗粒内部孔隙体积增大，成品含有强亲水性基团、适度交联的功能性高分子材料，能够吸收自身重量几百倍的水分，且吸水膨胀后的凝胶体在加压的情况下，也不宜将水析出，可有效吸附水份，吸水率≥1000g/g，吸水速率≥100g/min，保压吸水率≥70g/g；
高吸水性树脂是一种含有羧基、羟基等强亲水性基团并具有一定交联度的水溶胀型高分子聚合物，特点是具有优越的吸水、保水能力，吸水量可达自身质量的数百倍，吸水率最高可达2000g/g，吸盐水率达75g/g，保压吸水率达90g/g，即使在受热、加压条件下也不易失水，对光、热、酸、碱的稳定性好，天然高分子加工产物合成高吸水树脂有淀粉类和纤维类，由淀粉—丙烯酸—交联性单体接枝共聚反应合成的SAP的吸水量，吸水速度非常快，并且保水性强，价格适中、安全性能较好，已经被广泛应用在一次性的纸尿布、成人失禁用品以及妇女卫生用品等个人护理产品中。作为功能性、易于降解的高分子材料，SAP已成为了生产一次性卫生护理垫的首选材料。
优选的，所述表面层包括与人体接触的面层和用于包封固定面层的内基层，所述面层为纯棉制成，所述内基层为PE材料制成的漏斗形状。面层干爽保证局部皮肤不受潮湿之苦，内基层的漏斗型设计优于桶状设计，渗入的液体不易回流。
优选的，所述底层上设有用于粘附于底裤、短裤或内衣上的粘扣。底层：选透气材料制成，它可使气体状的水分子顺利通过，从而达到及时排出湿气的作用，有效地减少护理垫与身体排出湿气的作用，有效地减少护理垫与身体之间的潮湿和闷热，保持干爽清新的感受。
一种具有杀菌作用的卫生护理垫的制备方法，制备得到表面层、吸收层和底层后，依次进行压合，再进行浸泡处理，所述浸泡处理过程为，分别称取大黄5kg、白芷5kg、黄柏5kg、樟脑2kg、薄荷4kg，加入重量4倍水熬制到1倍水，后将药液脱色处理至无色，将所述表面层和吸收层常温浸没在药液中15-30min。
优选的，所述大黄、白芷、黄柏、樟脑、薄荷为中草药，具有清热解毒、活血化瘀的作用，经过优选配伍，并将其中有效成分提取处理，制成液体，处理卫生护理垫表层材料和吸水层材料，使处理的材料具有消炎灭菌、活血化瘀作用。
大黄：具有清热解毒，止血，祛瘀，通便，杀虫的功效。大黄对多种病原菌有抑制作用，尤以葡萄球菌和淋病双球菌最敏感；对流感病毒、单纯疱疹病毒、乙肝病毒、柯萨奇病毒均有抑制作用；对阿米巴原虫、阴道滴虫、致病性真菌也有一定的抑制作用。大黄抑菌的有效成分主要为大黄酸、大黄素、芦荟大黄素。外用治跌打损伤，烧烫伤，痈疖肿毒，流行性腮腺炎，疥疮，湿疹，皮炎等；
白芷：多年生的草本植物，味香色白，以根入药，有祛病除湿、排脓生肌、活血止痛等功能，另外还具有抗菌、抗炎之功效。用于祛风湿，活血排脓，生肌止痛。治疗头痛、牙痛、鼻渊、肠风痔漏、痈疽疮疡、皮肤瘙痒等症；
黄柏：又名檗木、檗皮、黄檗。既能清热燥湿，又能泻火解毒。用来治疗疮疡肿毒，内服外用均可。此外，黄柏外用还可以用来治疗皮肤湿疹瘙痒不适等症。黄柏有广谱的抗菌作用，对多种真菌、滴虫有显著的抑制作用。黄柏还有有抗流感病毒的作用，对乙肝表面抗原有明显的选择性抑制作用。其机制与其对细菌呼吸和RNA合成的强烈抑制有关，还能明显减少金葡菌毒素的生成并促进白细胞对细菌的吞噬；
樟脑：别名韶脑、潮脑、脑子、油脑、树脑。具有通关窍、利滞气、辟秽浊、杀虫止痒、消肿止痛、除湿杀虫，温散止痛，开窍辟秽的功效。主治疥癣瘙痒、跌打伤痛、牙痛等症。樟脑涂于皮肤有温和的刺激及防腐作用；
薄荷：具有医用和食用双重功能。宣散风热，清头目，透疹。用于风热感冒，温病初起，头痛，目赤，喉痹，口疮，风疹，麻疹，胸胁涨闷。薄荷具有疏散风热、清利头目、理气解郁等功效。薄荷外用，治疗夏季痱子、蚊虫叮咬、疮疖等，用后清凉舒适；
上述5种中药材经过优选配伍，具有消炎灭菌、活血化瘀的作用，并将其中有效成分提取处理，制成液体，处理卫生护理垫表面层材料和吸收层材料，使处理的材料具有消炎灭菌、活血化瘀作用。
一种具有杀菌作用的卫生护理垫的制备方法，制备得到表面层、吸收层和底层后，依次进行压合，再进行浸泡处理，所述浸泡处理过程为分别称取新鲜蒲公英15kg，连翘、金银花、苍术各4kg，冰片1kg，再将新鲜蒲公英榨汁取浆，将连翘、金银花、苍术加入重量4倍水熬制到1倍水，取熬制后药液与蒲公英浆液混合，加入冰片，后将药液脱色处理至无色，将所述表面层和吸收层常温浸没在药液中15-30min。
连翘：(Forsythia suspensa)又名黄花条、连壳、青翘、落翘、旱连子、黄奇丹等。果实入药。性味苦凉微寒。具有清热，解毒，散结，消肿的功效。治温热，丹毒，斑疹，痈疡肿毒，瘰疬。连翘在体外可抑制伤寒杆菌、副伤寒杆菌、大肠杆菌、白喉杆菌、霍乱弧菌、链球菌等。对痢疾杆菌、金黄色葡萄球菌也有较好的抑制作用；
蒲公英：别名谷谷丁、婆婆丁、黄花苗、黄花地丁、奶汁草等，以全草入药，有清热解毒、消痛散结之功能，治疗急性乳腺炎，淋巴腺炎，瘰疠，疔毒疮肿，急性结膜炎，感冒发热，急性扁桃体炎，急性支气管炎、尿路感染等症。蒲公英对金黄色葡萄耐药菌株、溶血性链球菌有较强的杀菌作用，对绿脓杆菌、痢疾杆菌有抑制作用，有清热解毒、活血凉血、去腐生肌、祛风散结、消炎镇痛、杀虫止痒、抗感染和润肤等功效；
金银花：(Lonicera japonica)又名忍冬。其功效主要是清热解毒，主治温病发热、热毒血痢、痈疽疔毒等。金银花含有绿原酸、木犀草素苷等药理活性成分，对溶血性链球菌、金黄葡萄球菌等多种致病菌及病毒等有较强的抑制力，金银花性寒，味甘，入肺、心、胃经，具有清热解毒、抗炎、补虚疗风的功效，主治胀满下疾、温病发热，热毒痈疡和肿瘤等症；
冰片：又名片脑、桔片、艾片、龙脑香、梅花冰片、羯布罗香、梅花脑、冰片脑、梅冰等，是由菊科艾纳香茎叶或樟科植物龙脑樟枝叶经水蒸汽蒸馏并重结晶而得。味辛、苦，微寒；归心、肝、肺经；清香宣散，具有开窍醒神，清热散毒，明目退翳的功效，主治热病高热神昏，中风痰厥惊痫，暑湿蒙蔽清窍，喉痹耳聋，口疮齿肿，疮痈疳痔，目赤肿痛，翳膜遮睛等症。亦有清热解毒、防腐生肌作用。苍术：又名山精、赤术、马蓟、青术、仙术等，为菊科植物南苍术或北苍术等的根茎，主要功效是散寒解表，除障明目，燥湿化痰，具有燥土利水，泄饮消痰，行瘀，开郁，去漏，化癣，除癥，理吞酸去腐，辟山川瘴疠，回筋骨之痿软，清溲溺之混浊的作用；
上述5种中药材经过优选配伍，具有治疗褥疮的作用，并将其中有效成分提取处理，制成液体，处理卫生护理垫表面层材料和吸收层材料，使处理的材料具有防止褥疮生长作用。
本发明相对于现有技术，有以下优点：
本发明的一种具有杀菌作用的卫生护理垫，由PE膜、无纺布、绒毛浆、高分子吸水树脂等材质制成的一次性卫生用品，主要用于医院手术、妇科检查、产妇护理、幼儿看护、瘫痪病人大小便失禁等，卫生护理垫表面层采用柔软纯棉无纺布，渗透快，肌肤保持舒适，导流压纹，引导液体向四周扩散，保持干爽，吸收层主要成分为高分子吸水树脂(SAP)，确保快速有效吸收，通过对卫生护理垫所用材料进行中药药液浸泡处理，利用中草药连翘、蒲公英、金银花、冰片、苍术、大黄、白芷、黄柏、樟脑、薄荷等成分具有防止褥疮生长、消炎、活血化瘀的作用，使卫生护理垫具有独特的灭菌消炎、活血化瘀的作用，材料处理过程中利用中草药清热解毒、去腐生肌、活血化瘀等作用，将生产卫生护理垫的材料进行科学处理，使产品起到防止褥疮生长、消炎、活血化瘀的作用；
本发明的一种具有杀菌作用的卫生护理垫的制备方法，过程温和，环保安全，产品品质稳定。
【具体实施方式】
下面结合具体实施例对本发明作进一步描述：
实施例1-3
一种具有杀菌作用的卫生护理垫的制备方法：先制备表面层和底层；
制备吸收层：由45～55份糊化淀粉液、15～30份丙烯酸、10～12份丙烯酰胺、6～9份过硫酸钾、20～30份去离子水、10～15份纤维素接枝的聚丙烯酸酯、3～5份甘油、2～5份二氧化硅，在110～125℃条件搅拌混合并超声分散制得高吸水树脂，由高吸水树脂制成吸收层；
制备得到表面层、吸收层和底层后，依次进行压合，再进行浸泡处理，所述浸泡处理过程为，分别称取大黄5～10kg、白芷5～8kg、黄柏5～6kg、樟脑2～4kg、薄荷2～4kg，加入重量4倍水熬制到1倍水，后将药液脱色处理至无色，将所述表面层和吸收层常温浸没在药液中15～30min。
表1：实施例1-3各组分重量
| 实施例1 | 实施例2 | 实施例3 | |
| 大黄/kg | 5 | 10 | 8 |
| 白芷/kg | 5 | 8 | 6 |
| 黄柏/kg | 5 | 6 | 6 |
| 樟脑/kg | 2 | 3 | 4 |
| 薄荷/kg | 4 | 2 | 3 |
实施例4-6
一种具有杀菌作用的卫生护理垫的制备方法：先制备表面层和底层；
制备吸收层：由45～55份糊化淀粉液、15～30份丙烯酸、10～12份丙烯酰胺、6～9份过硫酸钾、20～30份去离子水、10～15份纤维素接枝的聚丙烯酸酯、3～5份甘油、2～5份二氧化硅，在110～125℃条件搅拌混合并超声分散制得高吸水树脂，由高吸水树脂制成吸收层；
制备得到表面层、吸收层和底层后，依次进行压合，再进行浸泡处理，所述浸泡处理过程为分别称取新鲜蒲公英10～15kg，连翘、金银花、苍术各4～6kg，冰片0.8～1.5kg，再将新鲜蒲公英榨汁取浆，将连翘、金银花、苍术加入重量4倍水熬制到1倍水，取熬制后药液与蒲公英浆液混合，加入冰片，后将药液脱色处理至无色，将所述表面层和吸收层常温浸没在药液中15～30min。
表2：实施例4-6各组分重量：
| 组分 | 实施例4 | 实施例5 | 实施例6 |
| 蒲公英/kg | 15 | 12 | 10 |
| 连翘/kg | 4 | 5 | 6 |
| 金银花/kg | 4 | 5 | 6 |
| 苍术/kg | 4 | 5 | 6 |
| 冰片/kg | 1 | 0.8 | 1.5 |
表3：实施例1-6吸收层的高吸水树脂的构成组分：
产品性能测试项目：
1、吸水率：材料完全湿透并经排空后，每单位质量的材料吸收液体的质量，以百分比表示。
计算公式：Wa＝[Mn-Mk/Mk]×100％
其中：Wa----吸水率，以百分比表示；
Mn----材料试验终点时重量。
Mk----材料的原质量。
2、吸水速率：试验材料被试验液体完全浸湿并将试验液体吸入材料内所需的时间。
3、卫生指标：材料要求不得检出：a、金黄色葡萄球菌；b、链球菌；c、真菌；d、霉菌。
4、荧光物质：在输出波长365nm的紫外灯下检验材料，记录材料是否有荧光。按照要求不得检出荧光物质。
实施例1-3材料物理性能如下：
实施例1-3卫生及其他指标：
1、金黄色葡萄球菌：未检出。
2、链球菌：未检出。
3、真菌：未检出。
4、霉菌：未检出。
5、荧光：未检出。
实施例1-3对比试验：
功能材料组：15位卧床病人使用中草药处理材料卫生护理垫，使用周期为10天，无一人生褥疮，病患恢复情况满意；
对照组：15位卧床病人使用普通材料卫生护理垫，使用周期为10天，其中3人生褥疮，其余12位病患恢复情况满意。
结论：本发明产品对防治褥疮有促进作用，有利于卧床病患快速恢复健康，起到具有杀菌作用的卫生护理垫作用。
实施例4-6材料物理性能如下：
实施例4-6卫生及其他指标：
1、金黄色葡萄球菌：未检出。
2、链球菌：未检出。
3、真菌：未检出。
4、霉菌：未检出。
5、荧光：未检出。
实施例4-6对比试验：
功能材料组：15位手术后病人使用中草药处理材料卫生护理垫，使用周期为7天，15位病患恢复情况满意。
对照组：15位手术后病人使用普通材料卫生护理垫，使用周期为7天，其中4人恢复较慢，其余11位病患恢复情况满意。
结论：本发明产品对伤口愈合具有促进作用，有利于术后病患快速恢复健康，起到具有杀菌作用的卫生护理垫作用。
Claims (3)
1.一种具有杀菌作用的卫生护理垫，其特征在于：由表面层、吸收层和底层构成，所述表面层由纯棉和PE网状材质组合构成，所述吸收层的主要成分为高吸水树脂，所述底层由透气材料制成，所述表面层和吸收层在组合后还经过中药药液浸泡处理；所述中药药液主要由大黄、白芷、黄柏、樟脑、和薄荷制成；
所述卫生护理垫的制备方法包括如下步骤：先制备表面层和底层；
制备吸收层：由45～55份糊化淀粉液、15～30份丙烯酸、10～12份丙烯酰胺、6～9份过硫酸钾、20～30份去离子水、10～15份纤维素接枝的聚丙烯酸酯、3～5份甘油、和2～5份二氧化硅，在110～125℃条件搅拌混合并超声分散制得高吸水树脂，由高吸水树脂制成吸收层；
制备得到表面层、吸收层和底层后，依次进行压合，再进行浸泡处理，所述浸泡处理过程为，分别称取大黄5～10kg、白芷5～8kg、黄柏5～6kg、樟脑2～4kg、和薄荷2～4kg，加入重量4倍水熬制到1倍水，后将药液脱色处理至无色，将所述表面层和吸收层常温浸没在药液中15～30min。
2.根据权利要求1所述的一种具有杀菌作用的卫生护理垫，其特征在于：所述表面层包括与人体接触的面层和用于包封固定面层的内基层，所述面层为纯棉制成，所述内基层为PE材料制成的漏斗形状。
3.根据权利要求1所述的一种具有杀菌作用的卫生护理垫，其特征在于：所述底层上设有用于粘附于底裤、短裤或内衣上的粘扣。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110748041.9A CN113318262A (zh) | 2018-05-28 | 2018-05-28 | 一种具有杀菌作用的卫生护理垫 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810522407.9A CN108578756B (zh) | 2018-05-28 | 2018-05-28 | 一种功能卫生护理垫及其制备方法 |
| CN202110748041.9A CN113318262A (zh) | 2018-05-28 | 2018-05-28 | 一种具有杀菌作用的卫生护理垫 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810522407.9A Division CN108578756B (zh) | 2018-05-28 | 2018-05-28 | 一种功能卫生护理垫及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113318262A true CN113318262A (zh) | 2021-08-31 |
Family
ID=63629337
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110748041.9A Pending CN113318262A (zh) | 2018-05-28 | 2018-05-28 | 一种具有杀菌作用的卫生护理垫 |
| CN202110749921.8A Pending CN113413482A (zh) | 2018-05-28 | 2018-05-28 | 一种具有防止褥疮生长作用的卫生护理垫 |
| CN201810522407.9A Active CN108578756B (zh) | 2018-05-28 | 2018-05-28 | 一种功能卫生护理垫及其制备方法 |
| CN202110748030.0A Pending CN113456879A (zh) | 2018-05-28 | 2018-05-28 | 一种能够清热解毒的功能卫生护理垫及其制备方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110749921.8A Pending CN113413482A (zh) | 2018-05-28 | 2018-05-28 | 一种具有防止褥疮生长作用的卫生护理垫 |
| CN201810522407.9A Active CN108578756B (zh) | 2018-05-28 | 2018-05-28 | 一种功能卫生护理垫及其制备方法 |
| CN202110748030.0A Pending CN113456879A (zh) | 2018-05-28 | 2018-05-28 | 一种能够清热解毒的功能卫生护理垫及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (4) | CN113318262A (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109045143A (zh) * | 2018-10-17 | 2018-12-21 | 佛山市妇幼保健院 | 一种中药会阴冰敷垫的制造方法 |
| CN110067098B (zh) * | 2019-03-28 | 2023-10-20 | 海宁市亿康纺织有限公司 | 一种速干凉感护理垫的制作方法及其装置 |
| CN110433323A (zh) * | 2019-08-21 | 2019-11-12 | 东莞苏氏卫生用品有限公司 | 一种含有功能护肤成分的高吸水性树脂、制备方法及一次性吸收用品 |
| CN111671574A (zh) * | 2020-07-17 | 2020-09-18 | 河南省戈尔医疗器械有限公司 | 一种医用护理垫及其制备方法 |
| CN112220961B (zh) * | 2020-09-14 | 2022-11-04 | 株洲千金药业股份有限公司 | 一种防褥除臭芯片与产妇垫及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030028163A1 (en) * | 2001-07-10 | 2003-02-06 | I Shan Lin | Additive for a sanitary napkin and a method of adding the same |
| CN101985050A (zh) * | 2010-09-21 | 2011-03-16 | 珠海圣原生物科技有限公司 | 卫生用品 |
| CN101987207A (zh) * | 2010-11-01 | 2011-03-23 | 南京斯瑞奇医疗用品有限公司 | 一种创面敷料水胶体及其制备方法 |
| US20150190543A1 (en) * | 2014-01-06 | 2015-07-09 | Verdex Technologies Inc. | Coform nanofibrous superabsorbent materials |
| WO2017079764A1 (en) * | 2015-11-06 | 2017-05-11 | Bkr Ip Holdco Llc | Method for the attenuation enhancement of absorbent materials used in both passive and active transdermal drug delivery systems |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60139374D1 (de) * | 2000-11-16 | 2009-09-10 | Mcneil Ppc Inc | Damenbinde mit einzelnen Abschnitten unterschiedlicher Flexibilität |
| CN101053671A (zh) * | 2007-05-23 | 2007-10-17 | 刘树平 | 一种药物卫生巾及其生产方法 |
| CN102850706B (zh) * | 2012-09-18 | 2014-12-31 | 福州大学 | 一种醚化淀粉接枝共聚物高吸水性树脂及其制备方法 |
| CN103431950A (zh) * | 2013-08-29 | 2013-12-11 | 吴天鹏 | 一种负离子草本卫生巾及其制作方法 |
| CN103739784A (zh) * | 2014-01-15 | 2014-04-23 | 东北师范大学 | 一种硅藻土复合高吸水树脂材料及其制备方法 |
| CN204274796U (zh) * | 2014-11-10 | 2015-04-22 | 稳健医疗（黄冈）有限公司 | 一种纯棉卫生用品 |
| CN105218734A (zh) * | 2015-04-18 | 2016-01-06 | 泉州邦丽达科技实业有限公司 | 一种抗菌、除臭的高吸水性树脂及其制备方法 |
| CN106620820A (zh) * | 2016-12-20 | 2017-05-10 | 山东益母妇女用品有限公司 | 具有缓解痔疮疼痛作用的卫生用品 |
| CN106580561A (zh) * | 2017-01-16 | 2017-04-26 | 东华大学 | 一种可生物降解的婴儿纸尿裤及其制备方法 |
-
2018
- 2018-05-28 CN CN202110748041.9A patent/CN113318262A/zh active Pending
- 2018-05-28 CN CN202110749921.8A patent/CN113413482A/zh active Pending
- 2018-05-28 CN CN201810522407.9A patent/CN108578756B/zh active Active
- 2018-05-28 CN CN202110748030.0A patent/CN113456879A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030028163A1 (en) * | 2001-07-10 | 2003-02-06 | I Shan Lin | Additive for a sanitary napkin and a method of adding the same |
| CN101985050A (zh) * | 2010-09-21 | 2011-03-16 | 珠海圣原生物科技有限公司 | 卫生用品 |
| CN101987207A (zh) * | 2010-11-01 | 2011-03-23 | 南京斯瑞奇医疗用品有限公司 | 一种创面敷料水胶体及其制备方法 |
| US20150190543A1 (en) * | 2014-01-06 | 2015-07-09 | Verdex Technologies Inc. | Coform nanofibrous superabsorbent materials |
| WO2017079764A1 (en) * | 2015-11-06 | 2017-05-11 | Bkr Ip Holdco Llc | Method for the attenuation enhancement of absorbent materials used in both passive and active transdermal drug delivery systems |
Non-Patent Citations (3)
| Title |
|---|
| 姜绍通等: "淀粉基高吸水树脂的制备新方法", 《合肥工业大学学报(自然科学版)》 * |
| 张旺玺: "高吸水丙烯酸系树脂的制备方法和新进展", 《中原工学院学报》 * |
| 郭丹峰: "淀粉—丙烯酸—丙烯酰胺复合高吸水树脂的制备与性能", 《中国优秀博硕士学位论文全文数据库(硕士) 工程科技Ⅰ辑》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113413482A (zh) | 2021-09-21 |
| CN113456879A (zh) | 2021-10-01 |
| CN108578756B (zh) | 2021-08-03 |
| CN108578756A (zh) | 2018-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108578756B (zh) | 一种功能卫生护理垫及其制备方法 | |
| CN102145111B (zh) | 一种治疗霉菌性阴道炎的中药组合物及其制备方法 | |
| CN103316261A (zh) | 一种医用抗菌液及其制备方法 | |
| CN104921568B (zh) | 一种广谱抗菌型负离子地毯 | |
| CN102697857B (zh) | 一种防治产褥感染的产妇巾药水及其制备方法 | |
| CN105288711A (zh) | 一种含有中药的女用卫生护垫 | |
| CN105213112A (zh) | 一种具有抑菌保健功能的经期护理片 | |
| CN106309325A (zh) | 一种抗菌消炎漱口水及其制备方法 | |
| CN108553654A (zh) | 一种b超用耦合剂及其制备方法 | |
| CN104906465A (zh) | 一种治疗妇女慢性盆腔炎的中药化瘀组合物及其制备方法 | |
| CN106693035B (zh) | 植物抑菌除味功能的卫生巾芯片 | |
| CN106943618B (zh) | 一种艾草保健卫生巾及其制备方法 | |
| CN114869945A (zh) | 一种治疗皮肤创伤溃烂的中药组合物、制剂及其制备方法、应用 | |
| CN107899004A (zh) | 一种治疗阴道炎的液体凝胶敷料及其制备方法 | |
| CN106309598A (zh) | 一种用于伤口清洗的中药护理液及其制备方法 | |
| CN103599437B (zh) | 一种治疗阴道炎的中药药液 | |
| KR20200119771A (ko) | 천연물을 포함하는 항균비누 | |
| CN1246001C (zh) | 治疗妇女阴道炎疾病的中药制剂及其制备方法 | |
| CN104922449A (zh) | 一种中药消毒液及其制备方法 | |
| CN104306707A (zh) | 一种治疗褥疮的药物组合物 | |
| CN105560687A (zh) | 一种治疗皮肤溃疡的复方外用中药涂敷液及其制备方法和应用 | |
| CN103585321A (zh) | 一种外用治疗滴虫性阴道炎的中药组合物 | |
| CN106389280A (zh) | 一种痤疮肌肤专用保湿喷雾剂及其制备方法 | |
| CN104127765B (zh) | 一种治疗皮肤癣的滴剂及其制备方法 | |
| CN105079337A (zh) | 一种预防褥疮的护理液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210831 |
|
| RJ01 | Rejection of invention patent application after publication |